MAM

MPM Asset Management Portfolio holdings

AUM $43.3M
This Quarter Return
-3.13%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$650M
AUM Growth
+$650M
Cap. Flow
+$96.7M
Cap. Flow %
14.87%
Top 10 Hldgs %
99.53%
Holding
16
New
1
Increased
–
Reduced
4
Closed
–

Top Buys

1
CHMA
Chiasma, Inc. Common Stock
CHMA
$113M

Top Sells

1
PETX
Aratana Therapeutics, Inc.
PETX
$8.47M
2
NVRO
NEVRO CORP.
NVRO
$6.72M
3
EPZM
Epizyme, Inc
EPZM
$661K
4
VSTM icon
Verastem
VSTM
$436K

Sector Composition

1 Healthcare 27%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
$404M 62.17% 5,831,253 – –
CHMA
2
DELISTED
Chiasma, Inc. Common Stock
CHMA
$113M 17.38% +5,681,544 New +$113M
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$52M 8% 1,220,672 – –
EPZM
4
DELISTED
Epizyme, Inc
EPZM
$22.2M 3.42% 1,729,674 -51,412 -3% -$661K
TARA icon
5
Protara Therapeutics
TARA
$120M
$13.7M 2.1% 983,381 – –
NVRO
6
DELISTED
NEVRO CORP.
NVRO
$9.83M 1.51% 211,884 -144,820 -41% -$6.72M
PETX
7
DELISTED
Aratana Therapeutics, Inc.
PETX
$9.46M 1.45% 1,117,875 -1,000,970 -47% -$8.47M
TRIV
8
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$8.88M 1.37% 1,776,692 – –
ALT icon
9
Altimmune
ALT
$338M
$8.44M 1.3% 6,347,614 – –
HSTO
10
DELISTED
Histogen Inc. Common Stock
HSTO
$5.31M 0.82% 1,192,080 – –
SVRA icon
11
Savara
SVRA
$567M
$1.48M 0.23% 2,551,851 – –
VSTM icon
12
Verastem
VSTM
$569M
$1.03M 0.16% 572,874 -243,809 -30% -$436K
ETRM
13
DELISTED
EnteroMedics Inc.
ETRM
$289K 0.04% 1,113,168 – –
SGMO icon
14
Sangamo Therapeutics
SGMO
$157M
$127K 0.02% 22,487 – –
CLCD
15
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$84K 0.01% 21,806 – –
MGNX icon
16
MacroGenics
MGNX
$112M
$68K 0.01% 3,168 – –